Molecular Devices Completes Acquisition of Axon Instruments

Molecular Devices of Sunnyvale, Calif., announced on July 1 that its acquisition of Australia-based Axon Instruments is complete.

The deal, in which Molecular Devices is paying approximately $68 million of cash in exchange for all outstanding shares of Axon, was originally announced on March 21. Molecular Devices said that as a result of the acquisition, it received approximately $26 million in cash that had been on Axon’s balance sheet.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

In Nature this week: ash dieback disease fungal genome, and more.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.